These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 15649482)
21. Simultaneous two-voxel localized (1)H-observed (13)C-edited spectroscopy for in vivo MRS on rat brain at 9.4T: Application to the investigation of excitotoxic lesions. Doan BT; Autret G; Mispelter J; Méric P; Même W; Montécot-Dubourg C; Corrèze JL; Szeremeta F; Gillet B; Beloeil JC J Magn Reson; 2009 May; 198(1):94-104. PubMed ID: 19289293 [TBL] [Abstract][Full Text] [Related]
22. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats. Konieczny J; Wardas J; Kuter K; Pilc A; Ossowska K Neuroscience; 2007 Mar; 145(2):611-20. PubMed ID: 17224239 [TBL] [Abstract][Full Text] [Related]
23. Toward dynamic isotopomer analysis in the rat brain in vivo: automatic quantitation of 13C NMR spectra using LCModel. Henry PG; Oz G; Provencher S; Gruetter R NMR Biomed; 2003; 16(6-7):400-12. PubMed ID: 14679502 [TBL] [Abstract][Full Text] [Related]
24. The first in vivo observation of (13)C-(15)N coupling in mammalian brain. Kanamori K; Ross BD J Magn Reson; 2001 Dec; 153(2):193-202. PubMed ID: 11740894 [TBL] [Abstract][Full Text] [Related]
25. Mechanisms underlying Li+ effects in glutamatergic and GABAergic neurotransmissions in the adult rat brain and in primary cultures of neural cells as revealed by 13C NMR. Fonseca CP; Sierra A; Geraldes CF; Cerdán S; Castro MM J Neurosci Res; 2009 Mar; 87(4):1046-55. PubMed ID: 18855940 [TBL] [Abstract][Full Text] [Related]
26. Induction of GAP-43 modulates neuroplasticity in PBSC (CD34+) implanted-Parkinson's model. Shyu WC; Li KW; Peng HF; Lin SZ; Liu RS; Wang HJ; Su CY; Lee YJ; Li H J Neurosci Res; 2009 Jul; 87(9):2020-33. PubMed ID: 19235891 [TBL] [Abstract][Full Text] [Related]
27. Glutamine cycling in isolated working rat heart. Cohen DM; Guthrie PH; Gao X; Sakai R; Taegtmeyer H Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1312-6. PubMed ID: 12944323 [TBL] [Abstract][Full Text] [Related]
28. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion. Dal Bo G; Bérubé-Carrière N; Mendez JA; Leo D; Riad M; Descarries L; Lévesque D; Trudeau LE Neuroscience; 2008 Sep; 156(1):59-70. PubMed ID: 18706980 [TBL] [Abstract][Full Text] [Related]
29. Pleiotrophin receptor RPTP-zeta/beta expression is up-regulated by L-DOPA in striatal medium spiny neurons of parkinsonian rats. Ferrario JE; Rojas-Mayorquín AE; Saldaña-Ortega M; Salum C; Gomes MZ; Hunot S; Raisman-Vozari R J Neurochem; 2008 Oct; 107(2):443-52. PubMed ID: 18752647 [TBL] [Abstract][Full Text] [Related]
30. Iptakalim hydrochloride protects cells against neurotoxin-induced glutamate transporter dysfunction in in vitro and in vivo models. Yang YL; Meng CH; Ding JH; He HR; Ellsworth K; Wu J; Hu G Brain Res; 2005 Jul; 1049(1):80-8. PubMed ID: 15932749 [TBL] [Abstract][Full Text] [Related]
31. Repeated injection of MK801: an animal model of schizophrenia? Eyjolfsson EM; Brenner E; Kondziella D; Sonnewald U Neurochem Int; 2006; 48(6-7):541-6. PubMed ID: 16517016 [TBL] [Abstract][Full Text] [Related]
32. Repeated l-DOPA treatment increases c-fos and BDNF mRNAs in the subthalamic nucleus in the 6-OHDA rat model of Parkinson's disease. Zhang X; Andren PE; Svenningsson P Brain Res; 2006 Jun; 1095(1):207-10. PubMed ID: 16725125 [TBL] [Abstract][Full Text] [Related]
33. MRL/lpr mice have alterations in brain metabolism as shown with [1H-13C] NMR spectroscopy. Alexander JJ; Zwingmann C; Quigg R Neurochem Int; 2005 Jul; 47(1-2):143-51. PubMed ID: 15893408 [TBL] [Abstract][Full Text] [Related]
34. Assessment of metabolic changes in the striatum of a rat model of parkinsonism: an in vivo (1)H MRS study. Kickler N; Lacombe E; Chassain C; Durif F; Krainik A; Farion R; Provent P; Segebarth C; Rémy C; Savasta M NMR Biomed; 2009 Feb; 22(2):207-12. PubMed ID: 19130495 [TBL] [Abstract][Full Text] [Related]
35. Neuronal-glial interactions in rats fed a ketogenic diet. Melø TM; Nehlig A; Sonnewald U Neurochem Int; 2006; 48(6-7):498-507. PubMed ID: 16542760 [TBL] [Abstract][Full Text] [Related]
36. Changes on 5-HT2 receptor mRNAs in striatum and subthalamic nucleus in Parkinson's disease model. Zhang X; Andren PE; Svenningsson P Physiol Behav; 2007 Sep; 92(1-2):29-33. PubMed ID: 17588622 [TBL] [Abstract][Full Text] [Related]
37. Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats. Glavan G; Zivin M Neuroscience; 2005; 135(2):545-54. PubMed ID: 16111820 [TBL] [Abstract][Full Text] [Related]
38. Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease. Dekundy A; Pietraszek M; Schaefer D; Cenci MA; Danysz W Brain Res Bull; 2006 Apr; 69(3):318-26. PubMed ID: 16564428 [TBL] [Abstract][Full Text] [Related]
39. Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study. Yang J; Hu LF; Liu X; Zhou F; Ding JH; Hu G Life Sci; 2006 Mar; 78(17):1940-4. PubMed ID: 16216278 [TBL] [Abstract][Full Text] [Related]
40. Quantification of amounts and (13)C content of metabolites in brain tissue using high- resolution magic angle spinning (13)C NMR spectroscopy. Risa O; Melø TM; Sonnewald U NMR Biomed; 2009 Apr; 22(3):266-71. PubMed ID: 19012315 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]